Page last updated: 2024-12-11

pyracrenic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pyracrenic acid: a lupane from bark of Pyracantha crenulata; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
PyracanthagenusA plant genus of the family ROSACEAE widely cultivated as a prickly hedge with bright red berries. Members contain pyracrenic acid (a lupane triterpenoid).[MeSH]RosaceaeThe rose plant family in the order ROSALES and class Magnoliopsida. They are generally woody plants. A number of the species of this family contain cyanogenic compounds.[MeSH]

Cross-References

ID SourceID
PubMed CID6439576
CHEMBL ID1077309
CHEBI ID70671
SCHEMBL ID14374258
MeSH IDM0105333

Synonyms (14)

Synonym
lup-20(29)-en-28-oic acid, 3-((3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl)oxy)-, (3beta(e))-
80832-44-6
pyracrenic acid
betulinic acid 3beta-caffeate
betulinic acid 3beta-transcaffeate
CHEMBL1077309
chebi:70671 ,
(1r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-9-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid
3beta-o-trans-caffeoylbetulinic acid
SCHEMBL14374258
Q27139003
AKOS040762251
CS-0106550
HY-130294
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
triterpenoidAny terpenoid derived from a triterpene. The term includes compounds in which the C30 skeleton of the parent triterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID1197349Cytotoxicity against human SK-MEL-28 cells assessed as growth inhibition2015European journal of medicinal chemistry, Mar-06, Volume: 92Medicinal uses, phytochemistry and pharmacology of family Sterculiaceae: a review.
AID1364707Cytotoxicity against human SKOV3 cells assessed as inhibition of cell growth by SRB assay2017Journal of natural products, 04-28, Volume: 80, Issue:4
Bioactive Triterpenoids from the Twigs of Chaenomeles sinensis.
AID464580Cytotoxicity against human SKOV3 cells by SRB assay2010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Bioactivity-guided isolation of cytotoxic triterpenoids from the trunk of Berberis koreana.
AID663478Inhibition of Dengue virus NS5 polymerase assessed as inhibition of radiolabeled guanosine incorporation into homopolymeric cytosine RNA template by liquid scintillation counting2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Flacourtosides A-F, phenolic glycosides isolated from Flacourtia ramontchi.
AID1364711Cytotoxicity in rat C6 cells assessed as cell viability at 20 uM incubated for 24 hrs by MTT assay relative to untreated control2017Journal of natural products, 04-28, Volume: 80, Issue:4
Bioactive Triterpenoids from the Twigs of Chaenomeles sinensis.
AID464579Cytotoxicity against human A549 cells by SRB assay2010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Bioactivity-guided isolation of cytotoxic triterpenoids from the trunk of Berberis koreana.
AID1364708Cytotoxicity against human SK-MEL-2 cells assessed as inhibition of cell growth by SRB assay2017Journal of natural products, 04-28, Volume: 80, Issue:4
Bioactive Triterpenoids from the Twigs of Chaenomeles sinensis.
AID1364709Cytotoxicity against human HCT15 cells assessed as inhibition of cell growth by SRB assay2017Journal of natural products, 04-28, Volume: 80, Issue:4
Bioactive Triterpenoids from the Twigs of Chaenomeles sinensis.
AID663477Cytotoxicity against African green monkey Vero cells after 6 to 7 days by MTS assay2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Flacourtosides A-F, phenolic glycosides isolated from Flacourtia ramontchi.
AID464582Cytotoxicity against human HCT15 cells by SRB assay2010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Bioactivity-guided isolation of cytotoxic triterpenoids from the trunk of Berberis koreana.
AID1364710Neuroprotective activity in rat C6 cells assessed as induction of nerve growth factor secretion at 20 uM incubated for 24 hrs by ELISA method relative to untreated control2017Journal of natural products, 04-28, Volume: 80, Issue:4
Bioactive Triterpenoids from the Twigs of Chaenomeles sinensis.
AID464581Cytotoxicity against human SK-MEL-2 cells by SRB assay2010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Bioactivity-guided isolation of cytotoxic triterpenoids from the trunk of Berberis koreana.
AID1364706Cytotoxicity against human A549 cells assessed as inhibition of cell growth by SRB assay2017Journal of natural products, 04-28, Volume: 80, Issue:4
Bioactive Triterpenoids from the Twigs of Chaenomeles sinensis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (85.71)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.04 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index5.12 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]